These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9476722)

  • 1. A neurological evaluation of adult phenylketonuria in Northern Ireland.
    McDonnell GV; Esmonde TF; Hadden DR; Morrow JI
    Eur Neurol; 1998; 39(1):38-43. PubMed ID: 9476722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of the brain in phenylketonuria.
    Cleary MA; Walter JH; Wraith JE; Jenkins JP; Alani SM; Tyler K; Whittle D
    Lancet; 1994 Jul; 344(8915):87-90. PubMed ID: 7912392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency.
    Pietz J; Meyding-Lamadé UK; Schmidt H
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S69-73. PubMed ID: 8828614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and IQ.
    Jones SJ; Turano G; Kriss A; Shawkat F; Kendall B; Thompson AJ
    J Neurol Neurosurg Psychiatry; 1995 Sep; 59(3):260-5. PubMed ID: 7673953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings.
    Bick U; Ullrich K; Stöber U; Möller H; Schuierer G; Ludolph AC; Oberwittler C; Weglage J; Wendel U
    Eur J Pediatr; 1993 Dec; 152(12):1012-20. PubMed ID: 8131802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurophysiological studies of patients with classical phenylketonuria: evaluation of results of IQ scores, EEG and evoked potentials.
    Coşkun T; Topçu M; Ustündağ I; Ozalp I; Renda Y; Ciğer A; Nurlu G
    Turk J Pediatr; 1993; 35(1):1-10. PubMed ID: 8236512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological aspects of adult phenylketonuria.
    Pietz J
    Curr Opin Neurol; 1998 Dec; 11(6):679-88. PubMed ID: 9870137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter.
    Kono K; Okano Y; Nakayama K; Hase Y; Minamikawa S; Ozawa N; Yokote H; Inoue Y
    Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging of phenylketonuria.
    Shaw DW; Maravilla KR; Weinberger E; Garretson J; Trahms CM; Scott CR
    AJNR Am J Neuroradiol; 1991; 12(3):403-6. PubMed ID: 2058482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological deterioration in young adults with phenylketonuria.
    Thompson AJ; Smith I; Brenton D; Youl BD; Rylance G; Davidson DC; Kendall B; Lees AJ
    Lancet; 1990 Sep; 336(8715):602-5. PubMed ID: 1975386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of computerized neuropsychological tests and of nuclear magnetic resonance spectroscopy in clinical assessment of adult patients with phenylketonuria].
    Bik-Multanowski M; Pietrzyk JJ
    Przegl Lek; 2011; 68(3):127-31. PubMed ID: 21812225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status.
    Mercuri E; Muntoni F; Berardinelli A; Pennock J; Sewry C; Philpot J; Dubowitz V
    Neuropediatrics; 1995 Feb; 26(1):3-7. PubMed ID: 7791947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological outcome in 22 treated adolescents with hyperphenylalaninemia. A clinical and electrophysiological study.
    Ludolph AC; Ullrich K; Nedjat S; Masur H; Bick U
    Acta Neurol Scand; 1992 Apr; 85(4):243-8. PubMed ID: 1316707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of multimodality evoked potential abnormalities in sarcoidosis.
    Gott PS; Kumar V; Kadakia J; Sharma OP
    Sarcoidosis Vasc Diffuse Lung Dis; 1997 Sep; 14(2):159-64. PubMed ID: 9306507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment.
    Pietz J; Kreis R; Schmidt H; Meyding-Lamadé UK; Rupp A; Boesch C
    Radiology; 1996 Nov; 201(2):413-20. PubMed ID: 8888233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study.
    Mastrangelo M; Chiarotti F; Berillo L; Caputi C; Carducci C; Di Biasi C; Manti F; Nardecchia F; Leuzzi V
    Mol Genet Metab; 2015 Nov; 116(3):171-7. PubMed ID: 26283467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cranial MRI in PKU: evaluation of a critical threshold for blood phenylalanine.
    Ullrich K; Weglage J; Schuierer G; Fünders B; Pietsch M; Koch HG; Hahn-Ullrich H
    Neuropediatrics; 1994 Oct; 25(5):278-9. PubMed ID: 7885543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurological, neuropsychological, and ophthalmological evolution after one year of docosahexaenoic acid supplementation in phenylketonuric patients].
    Gutiérrez-Mata AP; Vilaseca MA; Capdevila-Cirera A; Vidal-Oller M; Alonso-Colmenero I; Colomé R; López-Sala A; Lambruschini-Ferri N; Gutiérrez A; Gassió R; Artuch R; Campistol J
    Rev Neurol; 2012 Aug; 55(4):200-6. PubMed ID: 22829083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global and regional volume changes in the brains of patients with phenylketonuria.
    Pérez-Dueñas B; Pujol J; Soriano-Mas C; Ortiz H; Artuch R; Vilaseca MA; Campistol J
    Neurology; 2006 Apr; 66(7):1074-8. PubMed ID: 16606920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.